Natera Inc logo

NTRA - Natera Inc Share Price

$114.52 3.7  3.3%

Last Trade - 9:00pm

Large Cap
Market Cap £7.01bn
Enterprise Value £6.77bn
Revenue £322.9m
Position in Universe 966th / 7022
Unlock NTRA Revenue
Relative Strength (%)
1m -6.09%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -12.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
190.4 212.5 209.6 257.7 302.3 391 571.5 693.5 +15.5%
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2021, Natera Increvenues increased 62% to $152.3M. Net loss increased 81%to $63.9M. Revenues reflect United States segment increaseof 67% to $145M, Europe, Middle East, India, Africa segmentincrease of 28% to $4.5M. Higher net loss reflects Selling,general and administrative increase of 48% to $89.7M(expense), Research and development - Balancing increasefrom $16.5M to $36.3M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


NTRA Revenue Unlock NTRA Revenue

Net Income

NTRA Net Income Unlock NTRA Revenue

Normalised EPS

NTRA Normalised EPS Unlock NTRA Revenue

PE Ratio Range

NTRA PE Ratio Range Unlock NTRA Revenue

Dividend Yield Range

NTRA Dividend Yield Range Unlock NTRA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
NTRA EPS Forecasts Unlock NTRA Revenue
Profile Summary

Natera, Inc. is a diagnostics company. The Company is engaged in the discovery, development and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children; Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle to select embryos with the probability of becoming healthy children; Anora Products of Conception test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing, to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mother's blood and a blood sample from the alleged father(s).

Last Annual December 31st, 2020
Last Interim March 31st, 2021
Incorporated January 26, 2007
Public Since July 2, 2015
No. of Shareholders: 12
No. of Employees: 1,815
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 87,943,997
Free Float (0.0%)
Eligible for
NTRA Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for NTRA
Upcoming Events for NTRA
Thursday 5th August, 2021
Q2 2021 Natera Inc Earnings Release
Thursday 5th August, 2021
Q2 2021 Natera Inc Earnings Call
Wednesday 3rd November, 2021 Estimate
Q3 2021 Natera Inc Earnings Release
Frequently Asked Questions for Natera Inc
What is the Natera Inc share price?

As of 9:00pm, shares in Natera Inc are trading at $114.52, giving the company a market capitalisation of £7.01bn. This share price information is delayed by 15 minutes.

How has the Natera Inc share price performed this year?

Shares in Natera Inc are currently trading at $114.52 and the price has moved by 0.123k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Natera Inc price has moved by 67.81% over the past year.

What are the analyst and broker recommendations for Natera Inc?

Of the analysts with advisory recommendations for Natera Inc, there are there are currently 4 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Natera Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Natera Inc next release its financial results?

Natera Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the Natera Inc dividend yield?

Natera Inc does not currently pay a dividend.

Does Natera Inc pay a dividend?

Natera Inc does not currently pay a dividend.

When does Natera Inc next pay dividends?

Natera Inc does not currently pay a dividend.

How do I buy Natera Inc shares?

To buy shares in Natera Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Natera Inc?

Shares in Natera Inc are currently trading at $114.52, giving the company a market capitalisation of £7.01bn.

Where are Natera Inc shares listed? Where are Natera Inc shares listed?

Here are the trading details for Natera Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: NTRA
What kind of share is Natera Inc?

Based on an overall assessment of its quality, value and momentum, Natera Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Natera Inc share price forecast 2021?

Shares in Natera Inc are currently priced at $114.52. At that level they are trading at 28.11% discount to the analyst consensus target price of 0.00.

Analysts covering Natera Inc currently have a consensus Earnings Per Share (EPS) forecast of -4.025 for the next financial year.

How can I tell whether the Natera Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Natera Inc. Over the past six months, the relative strength of its shares against the market has been -15.67%. At the current price of $114.52, shares in Natera Inc are trading at 9.18% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Natera Inc PE Ratio?

We were not able to find PE ratio data for Natera Inc.

Who are the key directors of Natera Inc?

Natera Inc's management team is headed by:

Matthew Rabinowitz - CHM
Jonathan Sheena - CFD
Steven Chapman - PRE
Roelof Botha - LED
Todd Cozzens - IND
Michael Brophy - CFO
Roy Baynes - IND
Robert Schueren - COO
Rowan Chapman - IND
Monica Bertagnolli - IND
Who are the major shareholders of Natera Inc?

Here are the top five shareholders of Natera Inc based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 8.21% (7.55m shares)
Fred Alger Management, LLC Investment Advisor/Hedge Fund
Percentage owned: 6.29% (5.78m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 5.47% (5.03m shares)
Wells Capital Management Inc. Investment Advisor/Hedge Fund
Percentage owned: 3.7% (3.40m shares)
Sofinnova Investments, Inc Venture Capital
Percentage owned: 3.37% (3.10m shares)
Similar to NTRA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.